The dysregulation of the NFκB pathway at different levels, either by mutations, epigenetic mechanisms or pharmacological means, is involved in many human diseases, especially chronic inflammation, immunodeficiency and cancer20, 21, 22, 23. The gene discussed is NFKB1; the disease is Immunodeficiency.